This issue brings together a small clinical trial about pain and an observational brain-imaging study. Both offer useful clues, but neither changes today’s treatment or testing standards.

Story 1

Electroacupuncture lowered pain scores, but the trial was small and short

🔍 How this came about

Researchers in China assigned 58 people with Parkinson’s and musculoskeletal pain to electroacupuncture or sham treatment. Both groups received one session a day for five days. Pain was measured immediately afterward and again two and four weeks later. Pain scores were lower in the electroacupuncture group, but motor, depression, anxiety and quality-of-life scores did not differ clearly between groups.

“Pain scores in the electroacupuncture group were lower than in the sham group after treatment and at two and four weeks; other between-group score differences were not statistically significant.”
— PubMed abstract
Read the original (Read the original)

✅ If you live with Parkinson’s

This was a small, short-term study of pain relief. It does not show that electroacupuncture treats Parkinson’s itself or improves motor function. New or worsening pain should first be assessed for its cause.

Do not start, stop or replace medication or rehabilitation based on this study. Tell a clinician before acupuncture, especially if you use blood thinners, have a skin infection or have an implanted cardiac device.

🙋 If you are a care partner

Note when pain begins, what movement makes it worse, and whether it relates to medication timing. That record is useful when discussing any supportive treatment.

A person seated while checking leg and foot pain
Story 2

MRI research found location-specific magnetic signals in the substantia nigra

🔍 How this came about

Researchers compared brain MRI scans from 21 newly diagnosed people, 27 people taking Parkinson’s medication and 29 healthy controls. They used quantitative susceptibility mapping, which is sensitive to materials such as iron, to examine several locations within the substantia nigra. Signal differences appeared in different locations across the Parkinson’s groups, and the patterns were not the same in newly diagnosed and medicated participants.

“The study found spatially varying changes and left-right asymmetry in nigral magnetic susceptibility across Parkinson's disease stages.”
— Journal of Neuroradiology abstract
Read the original (Read the original)

✅ If you live with Parkinson’s

This MRI approach is a research tool for understanding disease biology. It is not yet a standard test for deciding one person’s rate of progression or treatment.

🙋 If you are a care partner

If an MRI report worries you, ask what the scan was intended to check and whether its finding changes the care plan. A signal studied in research does not always have the same role in an individual’s care.


What you can do now

Record changes in pain or movement with dates and bring them to the next visit. New research can point to possibilities, but medication and rehabilitation plans should be changed only with your care team.

ParkinON rewrites recent research in plain language. This article is not medical diagnosis or treatment advice. Please discuss new treatments or tests with your care team.